Globalization of Clinical Trials and Clinical Research
The globalization of clinical research is a generally late wonder, in which a large portion of these reviews are occurring on a worldwide scale, with a huge increment of clinical trials in creating nations. Created showcases in the United States, Western Europe, Germany, Japan still produce the lion's share of clinical trial action. About 31% of the world's clinical trials are apparently directed outside of the United. As indicated by the report China, Japan, India, and Korea are the most dynamic settings for clinical trials among creating countries. It is anticipated that Japan as the world's second-biggest pharmaceutical market by 2015.
As per the Clinicaltrials.gov the aggregate number of studies enlisted in 2016 is 231,756. The rate of studies enlisted from United States is 37%, Non-U.S is 47%. It is evaluated to achieve more than 280,000 review registries by 2017.
- Globalization of drug development
- Ethical and scientific implications
- Comparative impact of globalization
- Mutual recognition of clinical study results
- Strategies for successful globalization of clinical trials
- Hospital Management
Related Conference of Globalization of Clinical Trials and Clinical Research
Globalization of Clinical Trials and Clinical Research Conference Speakers
Recommended Sessions
- Bioinformatics in Clinical Research
- Clinical and Medical Case Reports
- Clinical Data Management
- Clinical Research On Different Diseases
- Clinical Trial Site Management
- Clinical Trials and Clinical Research Conducts
- CRO (Contract Research Organization) Clinical Trials
- Drug Discovery and Development
- Entrepreneurs Investment Meet
- Ethics in Clinical Trials and Research
- Globalization of Clinical Trials and Clinical Research
- In Silico Clinical Trials
- Innovations in Clinical Trials and Research
- Nanotechnology in Clinical Trials and Research
- Outsourcing and Collaborative Research in Clinical Trials
- Patient Centric Clinical Trials
- Pharmacoepidemiology
- Pharmacogenomics
- Pharmacovigilance and Drug Safety
- Post Marketing Surveillance
- Risk assessment and management in clinical trials (QRM)